Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $32.9 million.

  • GeneDx Holdings' Other Accumulated Expenses rose 9912.73% to $32.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.9 million, marking a year-over-year increase of 9912.73%. This contributed to the annual value of $20.5 million for FY2024, which is 2547.75% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Other Accumulated Expenses is $32.9 million, which was up 9912.73% from $19.1 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Other Accumulated Expenses registered a high of $81.6 million during Q2 2022, and its lowest value of $11.1 million during Q2 2024.
  • Over the past 5 years, GeneDx Holdings' median Other Accumulated Expenses value was $23.4 million (recorded in 2022), while the average stood at $29.8 million.
  • As far as peak fluctuations go, GeneDx Holdings' Other Accumulated Expenses surged by 22958.73% in 2022, and later tumbled by 7559.76% in 2023.
  • Over the past 5 years, GeneDx Holdings' Other Accumulated Expenses (Quarter) stood at $33.4 million in 2021, then skyrocketed by 48.88% to $49.7 million in 2022, then tumbled by 67.13% to $16.3 million in 2023, then grew by 25.48% to $20.5 million in 2024, then soared by 60.3% to $32.9 million in 2025.
  • Its Other Accumulated Expenses was $32.9 million in Q3 2025, compared to $19.1 million in Q2 2025 and $24.6 million in Q1 2025.